Navigation Links
ReachMD Educational Program Highlights Asthma and Allergy Connections
Date:5/18/2016

Every day, more than 5,400 ER visits and at least 1,200 hospitalizations are a direct result of asthma complications.* Costing more than $56 billion in direct costs annually, asthma remains a critical public health challenge across the country.

“For too many, the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and better managed,” said Inderpal Randhawa, MD, Associate Clinical Professor of Pediatrics, UC Irvine School of Medicine and Associate Clinical Professor of Medicine, UCLA David Geffen School of Medicine. “A mainstay in asthma management is reducing exposure to allergic triggers – such as mold, smoke and dust. It’s important for anyone suffering with asthma to be tested for such triggers to reduce their risk of an asthma attack and its often avoidable costs and inherent inconveniences.”

A new expert clinical interview on ReachMD highlights a stepwise approach to managing asthma and discuss recommendations for testing for allergic triggers to reduce allergen exposure.

Designed for physicians and other healthcare providers who treat patients with asthma, the program provides a discussion on how the immune system reacts to allergens by producing IgE antibodies, which leads to an allergic reaction and its associated symptoms. The program broadcasts across the ReachMD network including the websites and mobile apps of ReachMD, iHeartRadio, Tunein, iTunes and Stitcher.

“IgE-specific testing helps identify allergic triggers, which in turn helps physicians recommend a patient-focused targeted exposure reduction program,” said Randhawa.“Patients can reduce symptoms and manage their disease, which ultimately improves quality of life and productivity.”

For healthcare providers treating the millions of Americans who suffer from asthma, this program provides key insights into appropriate testing to help guide targeted exposure reduction, as well as guideline-based care regimens.

“Allergy-like symptoms can be very difficult to differentiate from an upper respiratory disease,” said Mario Nacinovich, MSc, host of the program on ReachMD and Managing Partner at Axon Inc. “It is important to help physicians to accurately identify specific allergen sensitivities in order to confirm patient allergies.”

The program is sponsored by Quest Diagnostics.

About ReachMD
ReachMD lets healthcare professionals Be part of the knowledge® by discovering, participating in, and sharing medical education and clinical information through on demand programming and 24/7 streaming broadcasts. Its multi-channel network provides content online, on mobile, on air, and in enhanced automobiles dashboards. Its broadcast distribution network includes ReachMD, iHeartRadio, TuneIn, Stitcher, iTunes, and Apple Radio. ReachMD is the leading source nationwide of on air, online, and mobile medical education and information. For more information, visit http://www.reachmd.com.

Read the full story at http://www.prweb.com/releases/allergy/testing/prweb13421627.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. ‘Dying in America: Conversations About Care at the End of Life’ Launches on ReachMD, Highlights IOM’s Consensus Report on the Controversies and Complexities of Care
2. ReachMD Named Finalist for MM&M Award for ‘Best Healthcare Professional Media Brand’
3. ReachMD Launches Series Focusing on Parkinson’s Disease Psychosis
4. American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics
5. ReachMD Launches New Oncology Show Featuring Well-known Cancer Expert and Host, Selma Schimmel
6. ReachMD Radio Joins Clear Channel’s iHeartRadio
7. Mayo Clinic and ReachMD Launch “Updates from Mayo Clinic” Featuring Expert Interviews and Panel Discussions on Mental Health in Pediatric Primary Care
8. ReachMD Adds ‘Oncology Power Hour’ to Weekly Line Up, Delivering Expert Opinions and Medical Interviews to On Air, Online, and Mobile Learners
9. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
10. ReachMD on XM Satellite Radio Moves to Channel 245 Effective May 9, 2013
11. Complimentary Educational Seminar for Keratoconus Patients at Corneal Associates of New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... thermal denaturation in a cellular milieu; however, the broad application of this cellular ... simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods ...
(Date:4/21/2017)... ... April 21, 2017 , ... The University of Connecticut, ... funding to three startups through the UConn Innovation Fund. The $1.5 million UConn ... affiliated with UConn. , The UConn Innovation Fund provides investments of up to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... nourishing a range of emerging technology-based businesses, recently earned a $77,518 grant from ... , Founded in 2004, FITCI is Frederick’s first incubator. A non-profit corporation, ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , ... sciences and healthcare industries, is pleased to announce Holger Braemer as Vice ... “USDM Europe GmbH” based in Germany. , Braemer is an integral part of ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):